local & international
analysis & tools
products & services
Wednesday, 28 September 2016
Ebos Group Ordinary Shares
NZX : EBO
28 Sep 16 10:26
EBOS Group Limited supplies a range of medical, surgical, retail, dental, and scientific products to the healthcare market in New Zealand and Australia. It operates in two segments, Healthcare and Scientific. The Healthcare segment engages in the sale of healthcare products, as well as in retail healthcare and wholesale activities. The Scientific segment provides laboratory consumables, life sciences equipment, and technical support to industry and research laboratories. Ebos Group Limited serves hospitals, primary care centers, rehabilitation/mobility centers, aged care facilities, and allergists, as well as scientific and consumer markets. The company was formerly known as Ebos Dental & Surgical Supplies LTD and changed its name to Ebos Group Limited in 1986. Ebos Group Limited is headquartered in Christchurch, New Zealand.
Ebos Group Limited
Chapman Tripp Christchurch
COMPUTERSHARE INVESTOR SERVICES LIMITED
NZCDC Settlement System
52 wk High:
52 wk Low:
Intermed & Durables
108 Wrights Road
PO Box 411
Australia, New Zealand shares climb as Fed leaves rates steady
18:33 | 22/9/16
Mining giants BHP Billiton Ltd and Rio Tinto Ltd climbed 2.7 percent and 3.3 percent respectively. New Zealand's benchmark S&P/NZX 50 index recouped losses to rise 0.4 percent, or 30.54 points, to 7,311.71.
Pharmacies warned after Chemmart ACCC decision
14:26 | 12/9/16
Australian Journal of Pharmacy (registration) (blog)
The administrative undertaking is provided by EBOS Group Ltd, on behalf of its subsidiary Symbion Pty Ltd, the owner of the Chemmart pharmacy franchise.
Australian shares lower; New Zealand slightly higher
16:08 | 7/9/16
Business Recorder (registration) (blog)
New Zealand's benchmark S&P/NZX 50 index gained 0.2 percent, or 11.5 points, to finish the session at 7503.54. Gains in staples and utilities somewhat offset losses in healthcare and cyclicals stocks.
Asian Shares Advance; Australia Bucks Trend After RBA Decision
20:26 | 6/9/16
The benchmark S&P/NZX50 index rose 11.51 points or 0.15 percent to 7,503.54, with A2 Milk, Ebos Group, Contact Energy and Steel & Tube Holdings pacing gainers.
What's Ahead for EBOS Group Ltd. After Today's Gap Up?
05:11 | 27/8/16
The stock of EBOS Group Ltd. (ASX:EBO) gapped up by $0.27 today and has $46.10 target or 168.00% above today's $17.20 share price.
Ongoing Disclosure Notices
17:16 | 27/9/16
Ongoing Disclosure Notices End CA:00289846 For:EBO Type:RELINT Time:2016-09-27 17:16:11
Notification of Allotment of Securities
16:47 | 27/9/16
Notification of Allotment of Securities End CA:00289843 For:EBO Type:ALLOT Time:2016-09-27 16:47:17
Ongoing Disclosure Notice
12:45 | 19/9/16
Ongoing Disclosure Notice End CA:00289272 For:EBO Type:RELINT Time:2016-09-19 12:45:51
Section 209 Notice
11:49 | 15/9/16
Section 209 Notice End CA:00289080 For:EBO Type:S/HOLDER Time:2016-09-15 11:49:40
11:48 | 15/9/16
Proxy Form End CA:00289079 For:EBO Type:MEETING Time:2016-09-15 11:48:38
There are currently no comments on this topic.
Be the first person to Add a Comment...
ADD USER TO MY FAVOURITE
Customize your favourite:
Send me an alert when this user publishes new articles.
Add a Comment
You must be a registered user to post a comment:
If you are already registered, please
Add to Watchlist
Add to Portfolio
Add Email Alert
Most Viewed Stories
Billions wiped off the FTSE 100 after Merkel rules out rescue at Deutsche Bank
China Mobile Fights AT&T for Value Crown, Unicom on Users: Chart
Growing worries over SA's nuclear plans
FTSE 100 rises as investors find hope in Clinton-Trump debate
Nikkei 225 Recovers Higher From Support
Daily NZX Report
Daily Market Report
Daily Forex Report
Daily Global Report
Advertise Online With Us
Hosted by SPIDER
Limited. All the material on this page has the protection of international copyright. All rights reserved.
NZX Quotes are delayed at least 20 minutes. All information provided "as is" for informational purposes only, not intended for trading purposes or advice.
FinData will not be liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.
By accessing the FinData site, you agree not to redistribute the information found therein.